«
»

Avastin Shows No Benefit Against Early Stage Colon Cancer (HealthDay)

HealthDay – SATURDAY, May 30 (HealthDay News) — The cancer drug Avastin,
widely used for lung, breast and metastatic colorectal cancers, appears
ineffective for patients with early stage colon cancer, a result the
trial’s lead author called “disappointing.”

This entry was posted on Sunday, May 31st, 2009 at 8:36 am and is filed under Calator. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.